Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 69 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Keyword is Bone Density  [Clear All Filters]
2022
Anagnostis, P., Florentin M., Livadas S., Lambrinoudaki I., & Goulis D. G. (2022).  Bone Health in Patients with Dyslipidemias: An Underestimated Aspect.. Int J Mol Sci. 23(3), 
Vachliotis, I. D., Anastasilakis A. D., Goulas A., Goulis D. G., & Polyzos S. A. (2022).  Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications.. Diabetes Obes Metab. 24(9), 1702-1720.
2021
Skarakis, N. S., Mastorakos G., Georgopoulos N., & Goulis D. G. (2021).  Energy deficiency, menstrual disorders, and low bone mineral density in female athletes: a systematic review.. Hormones (Athens). 20(3), 439-448.
2019
Anagnostis, P., Siolos P., Gkekas N. K., Kosmidou N., Artzouchaltzi A-M., Christou K., et al. (2019).  Association between age at menopause and fracture risk: a systematic review and meta-analysis.. Endocrine. 63(2), 213-224.
Anagnostis, P., Lambrinoudaki I., Kenanidis E., Potoupnis M., Tsiridis E., & Goulis D. G. (2019).  Drug holidays in osteoporosis treatment: mind the gaps!. Osteoporos Int. 30(12), 2523-2524.
Kosti, K., Athanasiadis L., & Goulis D. G. (2019).  Long-term consequences of androgen insensitivity syndrome.. Maturitas. 127, 51-54.
Anagnostis, P., Gkekas N. K., Potoupnis M., Kenanidis E., Tsiridis E., & Goulis D. G. (2019).  New therapeutic targets for osteoporosis.. Maturitas. 120, 1-6.
2018
Anagnostis, P., Paschou S. A., Gkekas N. N., Artzouchaltzi A-M., Christou K., Stogiannou D., et al. (2018).  Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review.. Endocrine. 60(3), 373-383.
Polyzos, S. A., Anastasilakis A. D., Efstathiadou Z. A., Makras P., Perakakis N., Kountouras J., et al. (2018).  Irisin in metabolic diseases.. Endocrine. 59(2), 260-274.
Fontalis, A., Kenanidis E., Prousali E., Potoupnis M., & Tsiridis E. (2018).  Safety and efficacy of denosumab in osteoporotic patients previously treated with other medications: a systematic review and meta-analysis.. Expert Opin Drug Saf. 17(4), 413-428.
2017
Yavropoulou, M. P., Vaios V., Pikilidou M., Chryssogonidis I., Sachinidou M., Tournis S., et al. (2017).  Bone Quality Assessment as Measured by Trabecular Bone Score in Patients With End-Stage Renal Disease on Dialysis.. J Clin Densitom. 20(4), 490-497.
2016
Anagnostis, P., Karras S. N., Vakalopoulou S., & Terpos E. (2016).  Haemophilia and low bone mass. Ok, but what about fracture risk?. Haemophilia. 22(1), 11-4.
Tsentidis, C., Gourgiotis D., Kossiva L., Doulgeraki A., Marmarinos A., Galli-Tsinopoulou A., et al. (2016).  Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.. Osteoporos Int. 27(4), 1631-1643.
Makras, P., Polyzos S. A., & Anastasilakis A. D. (2016).  Letter to the Editor: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid.. J Clin Endocrinol Metab. 101(9), L89-90.
Mpalaris, V., Anagnostis P., Anastasilakis A. D., Goulis D. G., Doumas A., & Iakovou I. (2016).  Serum leptin, adiponectin and ghrelin concentrations in post-menopausal women: Is there an association with bone mineral density?. Maturitas. 88, 32-6.
2015
Anagnostis, P., Karras S. N., & Goulis D. G. (2015).  Bone disease in patients with haemophilia A and B--where are we now?. Haemophilia. 21(1), 1-3.
Anastasilakis, A. D., Polyzos S. A., Makras P., Gkiomisi A., Sakellariou G., Savvidis M., et al. (2015).  Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment.. Expert Opin Ther Targets. 19(3), 299-306.
Mpalaris, V., Anagnostis P., Goulis D. G., & Iakovou I. (2015).  Complex association between body weight and fracture risk in postmenopausal women.. Obes Rev. 16(3), 225-33.
Anastasilakis, A. D., Polyzos S. A., Efstathiadou Z. A., Savvidis M., Sakellariou G. T., Papatheodorou A., et al. (2015).  Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers.. Metabolism. 64(10), 1291-7.
Anastasilakis, A. D., Polyzos S. A., Gkiomisi A., Saridakis Z. G., Digkas D., Bisbinas I., et al. (2015).  Denosumab versus zoledronic acid in patients previously treated with zoledronic acid.. Osteoporos Int. 26(10), 2521-7.
Gkogka, C., Christoforidis A., Printza N., Kollios K., Kazantzidou E., & Papachristou F. (2015).  Longitudinal assessment of bone quality in pediatric patients with chronic kidney disease in relation to treatment modality.. J Bone Miner Metab. 33(3), 303-10.
Kenanidis, E., Potoupnis M. E., Kakoulidis P., Leonidou A., Sakellariou G. T., Sayegh F. E., et al. (2015).  Management of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk.. Expert Opin Drug Saf. 14(7), 1035-53.
Dounousi, E., Leivaditis K., Eleftheriadis T., & Liakopoulos V. (2015).  Osteoporosis after renal transplantation.. Int Urol Nephrol. 47(3), 503-11.
2014
Paschou, S. A., Anagnostis P., Karras S., Annweiler C., Vakalopoulou S., Garipidou V., et al. (2014).  Bone mineral density in men and children with haemophilia A and B: a systematic review and meta-analysis.. Osteoporos Int. 25(10), 2399-407.
Anastasilakis, A. D., Polyzos S. A., Makras P., Gkiomisi A., Bisbinas I., Katsarou A., et al. (2014).  Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months.. Osteoporos Int. 25(5), 1633-42.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές